Connect with us
We’re experimenting with AI-generated content to help deliver information faster and more efficiently.
While we try to keep things accurate, this content is part of an ongoing experiment and may not always be reliable.
Please double-check important details — we’re not responsible for how the information is used.

Diseases and Conditions

“Breaking the Cycle of Overmedication: A Digital Tool to Safely Reduce Harmful Prescriptions in Seniors”

McGill’s MedSafer tool helps doctors identify and eliminate risky or unneeded medications in seniors, significantly improving patient outcomes. It aims to prevent harmful “prescribing cascades” and could redefine standard care.

Avatar photo

Published

on

Breaking the Cycle of Overmedication: A Digital Tool to Safely Reduce Harmful Prescriptions in Seniors

For seniors, taking multiple medications can be a daily routine. However, this can often lead to adverse effects such as brain fog, falls, and fatigue. Researchers at McGill University have developed an innovative digital tool called MedSafer, which helps clinicians identify and safely reduce unnecessary or even harmful medications in seniors.

MedSafer is designed to work alongside the clinical review process, scanning a patient’s medication list and health conditions to flag potentially inappropriate drugs. In a recent trial involving 725 residents in long-term care homes in New Brunswick, the software helped deprescribe such medications in 36 percent of participants – nearly triple the number when reviews were done without MedSafer.

“We often blame aging for memory loss or mobility issues when the real culprit is the medications,” said Dr. Emily McDonald, lead author and Associate Professor at McGill’s Department of Medicine. “I’ve seen patients go from barely responsive to having conversations again after stopping a sedating medication.”

According to Dr. McDonald, nearly two-thirds of Canadian seniors take five or more medications a day, with an even higher number in long-term care. This phenomenon is known as a “prescribing cascade,” where medications often accumulate over time and are prescribed to counteract the side effects of other drugs.

MedSafer co-developer Dr. Todd Lee explained that this can lead to increased risks of falls, confusion, and hospitalizations, with more interactions and side effects occurring with each additional medication.

The researchers’ ultimate goal is to integrate MedSafer into primary care, addressing overmedication before patients enter long-term care. As Dr. McDonald put it, “This should be the new standard of care for older adults – no one should be on a medication that’s doing more harm than good.”

The study was funded by the Healthy Seniors Pilot Project, a joint initiative between the Public Health Agency of Canada and the Government of New Brunswick.

With MedSafer, clinicians can now have a powerful tool to help their patients break free from the cycle of overmedication. By reducing unnecessary medications, seniors can regain control over their lives, feel more empowered, and live healthier, happier lives.

Diabetes

Unlocking the Secret to a Calorie-Burning Furnace: Scientists Discover Key Amino Acid for Weight Loss

Cutting calories doesn’t just slim you down—it also reduces cysteine, an amino acid that flips fat cells from storage mode to fat-burning mode. Researchers found that lowering cysteine sparks the conversion of white fat into heat-producing brown fat, boosting metabolism and promoting weight loss in both humans and animal models.

Avatar photo

Published

on

The study, published in Nature Metabolism, reveals that consuming fewer calories is not the only way to improve health and lose weight. Researchers have discovered a specific sulfur-containing amino acid called cysteine as a key component in weight loss. When participants restricted their calorie intake, it resulted in reduced levels of cysteine in white fat cells.

The Pennington Biomedical researchers, Dr. Eric Ravussin and Dr. Krisztian Stadler, examined cysteine’s role in metabolism and found that it triggers the transition of white fat cells to brown fat cells. These more active fat cells burn energy to produce heat and maintain body temperature. When researchers restricted cysteine entirely in animal models, it drove high levels of weight loss and increased fat burning and browning of fat cells.

Dr. Stadler stated, “In addition to the dramatic weight loss and increase in fat burning resulting from the removal of cysteine, the amino acid is also central to redox balance and redox pathways in biology.” This suggests future weight management strategies that might not rely exclusively on reducing caloric intake.

The article is based on results from trials involving both human participants and animal models. For the human trials, researchers examined fat tissue samples taken from trial participants who had actively restricted calorie intake over a year. The exploration of these metabolites indicated a reduced level of cysteine.

Dr. Ravussin said, “Reverse translation of a human caloric restriction trial identified a new player in energy metabolism.” Systemic cysteine depletion in mice caused weight loss with increased fat utilization and browning of adipocytes.

The tissue samples came from participants in the CALERIE clinical trial, which recruited healthy young and middle-aged men and women who were instructed to reduce their calorie intake by an average of 14% over two years. With the reduction of cysteine, the participants also experienced subsequent weight loss, improved muscle health, and reduced inflammation.

In the animal models, researchers provided meals with reduced calories. This resulted in a 40% drop in body temperature, but regardless of the cellular stress, the animal models did not exhibit tissue damage, suggesting that protective systems may kick in when cysteine is low.

Dr. John Kirwan, Executive Director of Pennington Biomedical Research Center, stated, “Dr. Ravussin, Dr. Stadler, and their colleagues have made a remarkable discovery showing that cysteine regulates the transition from white to brown fat cells, opening new therapeutic avenues for treating obesity.” I would like to congratulate this research team on uncovering this important metabolic mechanism that could eventually transform how we approach weight management interventions.

Continue Reading

Animals

Nature’s Anti-Aging Hack? Jewel Wasp Larvae Slow Their Biological Clock

Scientists discovered that jewel wasp larvae that undergo a developmental “pause” live longer and age more slowly at the molecular level by nearly 30%. This slowdown is tied to conserved biological pathways, hinting at possible applications for human aging.

Avatar photo

Published

on

The discovery by scientists at the University of Leicester has revealed that jewel wasps can undergo a natural “time-out” as larvae before emerging into adulthood with this surprising advantage. The study, published in PNAS, shows that this pause in development within the wasp dramatically extends lifespan and decelerates the ticking of the so-called “epigenetic clock” that marks molecular aging.

Aging isn’t just about counting birthdays; it’s also a biological process that leaves molecular fingerprints on our DNA. One of the most accurate markers of this process is the epigenetic clock, which tracks chemical changes in DNA, known as methylation, that accumulate with age. The study found that by altering the course of development itself, the jewel wasps could slow down their aging process at a molecular level.

To investigate this phenomenon, a team of researchers exposed jewel wasp mothers to cold and darkness, triggering a hibernation-like state in their babies called diapause. This natural “pause button” extended the offsprings’ adult lifespan by over a third. Even more remarkably, the wasps that had gone through diapause aged 29% more slowly at the molecular level than their counterparts.

“It’s like the wasps who took a break early in life came back with extra time in the bank,” said Evolutionary Biology Professor Eamonn Mallon, senior author on the study. “It shows that aging isn’t set in stone; it can be slowed by the environment, even before adulthood begins.”

The researchers found that this molecular slowdown was linked to changes in key biological pathways that are conserved across species, including those involved in insulin and nutrient sensing. These same pathways are being targeted by anti-aging interventions in humans.

What makes this study novel and surprising is that it demonstrates a long-lasting, environmentally triggered slowdown of aging in a system that’s both simple and relevant to human biology. It offers compelling evidence that early life events can leave lasting marks not just on health but on the pace of biological aging itself.

Understanding how and why aging happens is a major scientific challenge. This study opens up new avenues for research, not just into the biology of wasps, but into the broader question of whether we might one day design interventions to slow aging at its molecular roots. With its genetic tools, measurable aging markers, and clear link between development and lifespan, Nasonia vitripennis is now a rising star in aging research.

“In short, this tiny wasp may hold big answers to how we can press pause on aging,” concluded Professor Mallon. Funding for the study was provided by The Leverhulme Trust and The Biotechnology and Biological Sciences Research Council (BBSRC).

Continue Reading

Animals

“Nature’s Armor: Scientists Uncover Gene Behind Aussie Skinks’ Immunity to Deadly Snake Venom”

Australian skinks have developed a remarkable genetic defense against venomous snake bites by mutating a key muscle receptor, making them resistant to neurotoxins. These tiny but powerful molecular changes mirror those found in cobra-resistant mammals like mongooses and honey badgers. This evolutionary arms race not only shows how adaptable life can be but also offers exciting possibilities for creating new antivenoms and therapies in human medicine.

Avatar photo

Published

on

The article has been rewritten to improve clarity, structure, and style while maintaining the core ideas:

Nature’s Armor: Scientists Uncover Gene Behind Aussie Skinks’ Immunity to Deadly Snake Venom

In a groundbreaking study led by the University of Queensland, scientists have discovered the genetic secret behind Australian skinks’ remarkable ability to withstand deadly snake venom. The research, published in the International Journal of Molecular Sciences, reveals that these small lizards have evolved a molecular armor to protect themselves from the toxic effects of neurotoxins.

Professor Bryan Fry from UQ’s School of the Environment explained that the skinks’ defense mechanism involves tiny changes in a critical muscle receptor called the nicotinic acetylcholine receptor. This receptor is normally targeted by snake venom, which blocks nerve-muscle communication and leads to rapid paralysis and death. However, in a stunning example of evolutionary adaptation, researchers found that skinks independently developed mutations on 25 occasions to block venom from attaching.

“It’s a testament to the massive evolutionary pressure exerted by venomous snakes after their arrival and spread across the Australian continent,” Professor Fry said. “The same mutations evolved in other animals like mongooses, which feed on cobras.”

Researchers confirmed that Australia’s Major Skink (Bellatorias frerei) has developed exactly the same resistance mutation as the honey badger, famous for its immunity to cobra venom.

To validate these findings, scientists conducted functional testing at UQ’s Adaptive Biotoxicology Laboratory. Dr. Uthpala Chandrasekara led the laboratory work and reported that the data was “crystal clear.” The modified receptors simply didn’t respond to toxins, demonstrating their remarkable ability to repel deadly snake venom.

This research has significant implications for biomedical innovation, particularly in the development of novel antivenoms or therapeutic agents. Dr. Chandrasekara emphasized that understanding how nature neutralizes venom can provide valuable clues for designing more effective treatments.

The project involved collaborations with museums across Australia and offers a promising example of interdisciplinary research, bridging the gap between scientific discovery and potential applications.

Continue Reading

Trending